Demographic, pathologic, and toxicological profiles of 127 decedents testing positive for ephedrine alkaloids

Forensic Science International

Volumn 139, Issue 1, 2004, Pages 61-69

  Blechman, Keith M ^a   Karch, Steven B ^b   Stephens, Boyd G ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY AND COUNTY OF SAN FRANCISCO   (United States)

Author keywords

Cocaine; Ephedrine; Phenylpropanolamine; Postmortem; Stimulant toxicity

Indexed keywords

CENTRAL STIMULANT AGENT; COCAINE; DRUG METABOLITE; EPHEDRINE; MORPHINE; NOREPHEDRINE; PSEUDOEPHEDRINE;

ADOLESCENT; ADULT; AGED; AUTOPSY; CADAVER; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; FATTY LIVER; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEAT STROKE; HUMAN; INJURY; ISOMER; MALE; NEPHROSCLEROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SCHOOL CHILD; TOXICITY;

EID: 0346365542     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2003.09.012     Document Type: Article

References (29)

1. Shekelle P.G., Hardy M.L., Morton S.C., Maglione M., Mojica W.A., Suttorp M.J., Rhodes S.L., Jungvig L., Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. J. Am. Med. Assoc. 289(12):2003;1537-1545.
2. Banner A.S., Sunderrajan E.V., Agarwal M.K., Addington W.W. Arrhythmogenic effects of orally administered bronchodilators. Arch. Intern. Med. 139(4):1979;434-437.
3. Dulfano M.J., Glass P. Evaluation of a new β2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine. Curr. Ther. Res. Clin. Exp. 15:1973;150-157.
4. James T.D., Lyons H.A. A comparative study of bronchodilator effects of carbuterol and ephedrine. J. Am. Med. Assoc. 241:1979;704-705.
5. Laitinen L.A., Empey D.W., Bye C., Britton M.G., McDonnell K., Hughes D.T. A comparison of the bronchodilator action of pseudoephedrine and ephedrine in patients with reversible airway obstruction. Eur. J. Clin. Pharmacol. 23:1982;107-109.
6. S.B. Karch, Karch's Pathology of Drug Abuse, 3rd ed., CRC Press, Boca Raton, FL, 2002, pp. 189-227.
7. US Food and Drug Administration, Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects. Evidence Report/Technology Assessment no. 76, 2003, pp. 1-4 (available at http://www.fda.gov/bbs/topics/NEWS/ephedra/summary.html, accessibility verified 9 April 2003).
8. Betz J.M., Gay M.L., Mossoba M.M., Adams S., Portz B.S. Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing ma huang. J. AOAC Int. 80(2):1997;303-315.
9. E.K. Kastrup (Ed.), Ephedrine. Drug Facts and Comparisons, 57th ed., Co., St. Louis, Facts and Comparisons, 2003, pp. 641-642.
10. Vansal S.S., Feller D.R. Direct effects of ephedrine isomers on human β-adrenergic receptor subtypes. Biochem. Pharmacol. 58(5):1999;807-810.
11. Alberts P., Bergstrom P.A., Fredrickson M.G. Characterisation of the functional alpha-adrenoceptor subtype in the isolated female pig urethra. Eur. J. Pharmacol. 371:1999;31-38.
12. Steinle J.J., Booz G.W., Day C.J., Granger H.J. Beta-3-adrenergic receptors regulate retinal endothelial cell migration and proliferation. J. Biol. Chem. 278(23):2002;20861-20866.
13. Travernier G., Barbe P., Galitzky J., Berlan M., Caput D., Lafontan M., Langin D. Expression of beta3-adrenoreceptors with low lipolytic action in human subcutaneous white adipocytes. Lipid Res. 37(1):1996;87-97.
14. De Matteis R., Arch J.R., Petroni M.L., Ferrari D., Cinti S., Stock M.J. Immunohistochemical identification of the beta(3)-adrenoceptor in human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int. J. Obes. Metab. Disord. 26(11):2002;1442-1450.
15. Kitzman D.W., Scholz D.G., Hagen P.T., Ilstrup D.M., Edwards W.D. Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity). A quantitative anatomic study of 765 specimens from subjects 20-99 years old. Mayo Clin. Proc. 63:1988;1237-1246.
16. Wilkinson G.R., Beckett A.H. Absorption, metabolism and excretion of the ephedrines in man. II. Pharmacokinetics. J. Pharm. Sci. 57:1968;1933-1938.
17. Welling P.G., Lee K.P., Patel J.A., Walker J.E., Wagner J.G. Urinary excretion of ephedrine in man without pH control following oral administration of three commercial ephedrine sulfate preparations. J. Pharm. Sci. 60:1971;1629-1634.
18. Pickup M.E., May C.S., Senadagrie R.S., Patterson J.W. The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. Br. J. Clin. Pharmacol. 3:1976;123-134.
19. Gurley B.J., Gardner S.F., White L.M., Wang P.L. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther. Drug Monit. 20(4):1998;439-445.
20. White L.M., Gardner S.F., Gurley B.J., Marx L.A., Wang P.L., Estes M. Pharmacokinetics and cardiovascular effects of ma huang (Ephedra sinica) in normotensive adults. J. Clin. Pharmacol. 37(2):1997;116-122.
21. Haller C.A., Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. NEJM. 343(25):2000;1833-1838.
22. Theoharides T.C. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang containing drink. J. Clin. Psychopharmacol. 17(5):1997;437-439.
23. Karch S.B., Green G.S., Young S. Myocardial hypertrophy and coronary artery disease in male cocaine users. J. Forensic Sci. 40(4):1995;591-595.
24. Karch S.B., Stephens B.G., Ho C. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J. Forensic Sci. 44(2):1999;359-368.
25. Karch S.B., Stephens B.G. Toxicology and pathology of deaths related to methadone: retrospective review. West. J. Med. 172:2000;11-14.
26. Karch S.B., Stephens B.G., Ho C.H. Relating cocaine blood concentrations to toxicity - an autopsy study of 99 cases. J. Forensic Sci. 43(1):1998;41-45.
27. Sever P.S., Dring L.G., Williams R.T. The metabolism of (-)-ephedrine in man. Eur. J. Clin. Pharmacol. 9(2-3):1975;193-198.
28. Kernan W.N., Viscoli C.M., Brass L.M., Broderick J.P., Brott T., Feldman E., Morgenstern L.B., Wilterdink J.L., Horwitz R.I. Phenylpropanolamine and the risk of hemorrhagic stroke. NEJM. 343(25):2000;1826-1832.
29. Haller C.A., Jacob P.P. III, Benowitz N.L. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin. Pharmacol. Ther. 71(6):2002;421-432.